000 | 01151 a2200337 4500 | ||
---|---|---|---|
005 | 20250517174516.0 | ||
264 | 0 | _c20180423 | |
008 | 201804s 0 0 eng d | ||
022 | _a2213-8595 | ||
024 | 7 |
_a10.1016/S2213-8587(17)30288-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBone, Henry G | |
245 | 0 | 0 |
_aDenosumab treatment in postmenopausal women with osteoporosis - Authors' reply. _h[electronic resource] |
260 |
_bThe lancet. Diabetes & endocrinology _c10 2017 |
||
300 |
_a768-769 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aAntibodies, Monoclonal |
650 | 0 | 4 | _aBone Density |
650 | 0 | 4 | _aBone Density Conservation Agents |
650 | 0 | 4 | _aDenosumab |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aOsteoporosis |
650 | 0 | 4 | _aOsteoporosis, Postmenopausal |
650 | 0 | 4 | _aPostmenopause |
700 | 1 | _aWagman, Rachel B | |
700 | 1 | _aPannacciulli, Nicola | |
700 | 1 | _aPapapoulos, Socrates | |
773 | 0 |
_tThe lancet. Diabetes & endocrinology _gvol. 5 _gno. 10 _gp. 768-769 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S2213-8587(17)30288-7 _zAvailable from publisher's website |
999 |
_c27593301 _d27593301 |